NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) - ANVISA Registration 10071770882

Access comprehensive regulatory information for NUCLEIC ACID OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 (HIV 1 AND 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770882 and manufactured by ABBOTT RAPID DIAGNOSTICS JENA GMBH. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Mar 27, 2027.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including ROCHE MOLECULAR SYSTEMS, INC, ZHEJIANG ORIENT GENE BIOTECH CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.